Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Glycemic Control Among Iranian People With Type 2 Diabetes: A Systematic Review and Meta-Analysis Publisher



Mohseni M1 ; Heidaribeni M2 ; Kelishadi R3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Services Management, Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Nutrition, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Diabetes in Developing Countries Published:2023


Abstract

Background: Glycemic control reduces the risk of cardiovascular complications among people with diabetes. However, the current status of glycemic control is uncertain among Iranian people with diabetes. This study aims to systematically review the studies on the status of glycemic control among people with type 2 diabetes in Iran. Methods: A systematic literature search was conducted in international databases including Medline database (PubMed), Web of Science, Google Scholar, and Scopus, as well as domestic databases such as Iran Medex, SID, Magiran, Irandoc, and Medlib, up to end of 2020. All observational studies (cross-sectional, case-control, and cohort) were included. Studies that reported the status of glycemic control among people with type 2 diabetes in Iran were selected. Good glycemic control was defined as glycated hemoglobin A1c (HbA1c) less than 7%. Results: A total of 23 eligible studies (15,358 patients) were included in the quantitative analysis. Of 15,358 patients, 5882 had good glycemic control. The pooled prevalence of good glycemic control was 33.1% (95% CI, 25.6–41.1%). Meta-regression showed no significant improvement in glycemic control rate by year. Conclusion: Despite the importance of good glycemic control in the prevention of micro- and macrovascular diabetic complications, the high proportion of Iranian people with type 2 diabetes remains poorly controlled. The result of this meta-analysis indicates the need for better approaches to diabetes management in Iran. © 2022, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India.
Related Docs
View other Related Docs
1. Dietary Glycemic Index and Insulin Index in Association With Incident Type 2 Diabetes Mellitus in Adults, British Journal of Nutrition (2025)
2. The Effect of Quality of Care on Cardiovascular Risk Factors in Newly Diagnosed Diabetic Patients, International Journal of Preventive Medicine (2014)
3. Glycated Hemoglobin As a Predictor for Metabolic Syndrome in an Iranian Population With Normal Glucose Tolerance, Metabolic Syndrome and Related Disorders (2012)
4. Quality of Care for First-Degree Relatives of Type 2 Diabetes Patients Diagnosed With Diabetes at a Screening Program One Year After Diagnosis, Review of Diabetic Studies (2008)
5. Associations of Dietary Glycemic Index and Glycemic Load With Glucose Intolerance in Iranian Adults, International Journal of Diabetes in Developing Countries (2014)
6. Diabetes and Impaired Glucose Regulation in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran: Prevalence and Risk Factors, Review of Diabetic Studies (2007)
7. Comparison of Glycated Hemoglobin With Fasting Plasma Glucose in Definition of Glycemic Component of the Metabolic Syndrome in an Iranian Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2012)
8. The Relationship Between Social Factors and Blood Glucose Control in Patients With Type Ii Diabetes in Isfahan Township, Iran, Journal of Isfahan Medical School (2017)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (49)
Roya Kelishadi (30)
Other Related Docs
9. Prevalence of Uncontrolled Diabetes and Its Predictors in Patients With Type 2 Diabetes Covered by Comprehensive Health Care Centers of Isfahan, Iranian Journal of Endocrinology and Metabolism (2022)
10. Diabetes and Associated Cardiovascular Risk Factors in Iran: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2007)
11. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
12. Incidence of Type 2 Diabetes by Hba1c and Ogtt: The Isfahan Diabetes Prevention Study, Acta Diabetologica (2012)
13. Developing a Program to Enhance Health Professionals′ Readiness to Evidence Utilization in Diabetes Care: A Mixed-Methods Protocol Study, Journal of Education and Health Promotion (2021)
14. Assessment of Caring Status for Patients With Type 2 Diabetes in Under Control Health Centers of Jarghoyee Region in Isfahan, Iran, Journal of Isfahan Medical School (2017)
15. Effects of Diabetes Definition on Global Surveillance of Diabetes Prevalence and Diagnosis: A Pooled Analysis of 96 Population-Based Studies With 331 288 Participants, The Lancet Diabetes and Endocrinology (2015)
16. Normal Fasting Plasma Glucose and Risk of Prediabetes and Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2011)
17. The Prevalence of Gestational Diabetes Mellitus in Iran (1993-2013): A Systematic Review, Journal of Isfahan Medical School (2014)
18. Cardiovascular Disease Risk Factors, Metabolic Syndrome and Obesity in an Iranian Population, Eastern Mediterranean Health Journal (2008)
19. Factors Related to Glycemic Control in Children and Adolescents With Type 1 Diabetes Mellitus in Isfahan, Iran, Journal of Diabetes and Metabolic Disorders (2021)
20. Worldwide Trends in Diabetes Since 1980: A Pooled Analysis of 751 Population-Based Studies With 4.4 Million Participants, The Lancet (2016)
21. Comparison of Fasting Glucose With Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2009)
22. Prevalence and Risk Factors of Diabetes Mellitus in the Isfahan City Population (Aged 40 or Over) in 1993, Diabetes Research and Clinical Practice (1997)
23. The Changes in Cardiovascular Disease Risk Factors After the Implementation of the Package of Essential Non-Communicable Disease Control, Journal of Cardiovascular and Thoracic Research (2024)
24. Should the First Degree Relatives of Type 2 Diabetic Patients With Isolated Impaired Fasting Glucose Be Considered for a Diabetes Primary Prevention Program?, Journal of Research in Medical Sciences (2010)
25. Diabetes and All-Cause Mortality, a 18-Year Follow-Up Study, Scientific reports (2020)
26. Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients With Type Ii Diabetes, Journal of Kerman University of Medical Sciences (2013)
27. People With Impaired Glucose Tolerance and Impaired Fasting Glucose Are Similarly Susceptible to Cardiovascular Disease: A Study in First-Degree Relatives of Type 2 Diabetic Patients, Annals of Nutrition and Metabolism (2010)
28. Utility of Hypertriglyceridemic Waist Phenotype for Predicting Incident Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Journal of Diabetes Investigation (2016)
29. Adherence to Glyburide and Metformin and Associated Factors in Type 2 Diabetes in Isfahan, Iran, Iranian Journal of Pharmaceutical Research (2011)
30. High Blood Pressure and Associated Cardiovascular Risk Factors in Iran: Isfahan Healthy Heart Programme, Medical Journal of Malaysia (2004)
31. Review of Epidemiology of Gestational Diabetes in Iran, Journal of Isfahan Medical School (2010)
32. Current Status of Glucose, Blood Pressure and Lipid Management in Type 2 Diabetes Clinic Attendees in Isfahan, Iran, Journal of Diabetes Investigation (2015)
33. Effect of Pharmacist-Led Patient Education on Glycemic Control of Type 2 Diabetics: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2011)
34. The Impact of Poor Glycemic Control on Lipid Profile Variables in Children With Type 1 Diabetes Mellitus, Journal of Education and Health Promotion (2019)
35. The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study, International Journal of Preventive Medicine (2016)
36. Effects of Gender and Height on the Oral Glucose Tolerance Test: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2008)
37. Effectiveness of Educational Intervention Based on Psychological Factors on Achieving Health Outcomes in Patients With Type 2 Diabetes, Diabetology and Metabolic Syndrome (2018)
38. Effect of Pharmacist-Led Patient Education on Glycemic Control of Type 2 Diabetics: A Randomized Controlled Trial, Journal of Research in Medical Sciences (2010)
39. Weight Change, Blood Pressure, Lipids and Glycemic Control Among Patients With Type 2 Diabetes, Annals of Nutrition and Metabolism (2011)
40. Barriers to Blood Glucose Level Management in the Health Care System: View Points of Patients, Families and Medical Personnel, Iranian Journal of Endocrinology and Metabolism (2012)
41. Predicting of Trend of Hemoglobin A1c in Type 2 Diabetes: A Longitudinal Linear Mixed Model, International Journal of Preventive Medicine (2014)
42. Association of Glycaemic Index and Glycaemic Load With Metabolic Syndrome in an Iranian Adult Population: Isfahan Healthy Heart Program, Nutrition and Dietetics (2017)
43. Hypertension in Type 2 Diabetes Mellitus in Isfahan, Iran: Incidence and Risk Factors, Diabetes Research and Clinical Practice (2005)
44. The Association Between Glycemic Index, Glycemic Load and Total Carbohydrate Intake and Risk of Premature Coronary Artery Disease: Iran Premature Coronary Artery Disease Study (Ipad) - a Case-Control Study, Nutrition, Metabolism and Cardiovascular Diseases (2024)
45. Prevalence of Macro- and Microvascular Complications Among Patients With Type 2 Diabetes in Iran: A Systematic Review, Diabetes Research and Clinical Practice (2009)
46. Metabolic Syndrome in First Degree Relatives of Patients With Type 2 Diabetes: Incidence and Risk Factors, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2011)
47. Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study, Diabetes Care (2016)
48. Progression to Impaired Glucose Metabolism in First-Degree Relatives of Patients With Type 2 Diabetes in Isfahan, Iran, Diabetes/Metabolism Research and Reviews (2009)
49. The Characteristics of Pre-Diabetic Patients Associated With Body Composition and Cardiovascular Disease Risk Factors in the Iranian Population, Journal of Research in Medical Sciences (2016)
50. The Product of Triglycerides and Glucose in Comparison With Fasting Plasma Glucose Did Not Improve Diabetes Prediction, Acta Diabetologica (2015)